Effect of age on toxicokinetics among human volunteers exposed to propylene glycol methyl ether (PGME)

Toxicology Letters

Volumn 211, Issue 1, 2012, Pages 77-84

  Hopf, Nancy B ^a   Vernez, David ^a   Berthet, Aurelie ^a   Charriere, Nicole ^a   Arnoux, Christine ^a   Tomicic, Catherine ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

1 Methoxy 2 propanol; Age; Biological monitoring; Human; PGME; Propylene glycol monomethyl ether

Indexed keywords

ETHER DERIVATIVE; PROPYLENE GLYCOL METHYL ETHER; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLIC PARAMETERS; POLLUTANT; PRIORITY JOURNAL; TOXICOKINETICS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; AGE FACTORS; AGED; AGING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; PROPYLENE GLYCOLS; SEX FACTORS; YOUNG ADULT;

EID: 84859328817     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.02.018     Document Type: Article

References (45)

1. ACGIH, 2011. Threshold limit values for chemical substances and physical agents and biological exposure indices. 2011 TLVs® and BEIs®. Publication #0111. American Conference of Governmental Industrial Hygienists, Cincinnati, OH. ISBN: 978-1-607260-28-8.
2. Bjørnerem Å., Straume B., Midtby M., Fønnebø V., Sundsfjord J., Svartberg J., Acharya G., Øian P., Rosvold Berntsen G.K. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø study. J. Clin. Endocr. Metab. 2004, 89:6039-6047.
3. Brooke I., Cocker J., Delic J.I., Payne M., Jones K., Gregg N.C., Dyne D. Dermal uptake of solvents from the vapour phase: an experimental study in humans. Ann. Occup. Hyg. 1998, 42:531-540.
4. Borghoff S., Birnbaum L. Age-related changes in glucuronidation and deglucuronidation in liver, small intestine, lung, and kidney of male Fischer rats. Drug Metab. Dispos. 1985, 13:62-67.
5. Birnbaum L. Pharmacokinetic basis of age-related changes in sensitivity to toxicants. Annu. Rev. Pharmacol. 1991, 31:101-128.
6. Corley R.A., Crissman J.W., Redmond J.M., McGuirk R.J., Cieszlak F.S., Stott W.T. Adaptive metabolic and pathologic changes following chronic inhalation of propylene glycol monomethyl ether in rats and mice. Occup. Hyg. 1996, 2:319-328.
7. Corley R.A., Gies R.A., Wu H., Weitz K.K. Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans. Toxicol. Lett. 2005, 156:193-213.
8. Corsonello A., Pedone C., Incalzi R.A. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr. Med. Chem. 2010, 17:571-584.
9. Dentan A., Devanthery A., de Peyer J.E., Droz P.O. Propylene glycol monomethyl ether (PGME) exposure. 2. Identification of products containing PGME their importance and their use in Switzerland. Int. Arch. Occup. Environ. Health 2000, 73:349-351.
10. Devanthery A., Berode M., Droz P.-O. Propylene glycol monomethyl ether occupational exposure. 3. Exposure of human volunteers. Int. Arch. Occup. Environ. Health 2002, 75:203-208.
11. Devanthéry, A., 2003.Toxico-cinétique et surveillance biologique du propylène glycol monométhyl éther. Etude sur des volontaires. Unpublished Ph.D. Thesis, Federal Polytechnic School of Lausanne, Switzerland.
12. DFG, D.F. List of MAK and BAT Values 2011 2011, Wiley-VCH, Weinheim.
13. Dickinson R.G., King A.R., McKinnon G.E., Hooper W.D., Eadie M.J., Herkes G.K. Studies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisal. Br. J. Clin. Pharm. 1993, 35:609-613.
14. Edwards O.M., Bayliss R.I., Millen S. Urinary creatinine excretion as an index of the completeness of 24-h urine collections. Lancet 1969, 2:1165-1166.
15. ElDesoky E.S. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am. J. Ther. 2007, 14:488-498.
16. Ginsberg G., Hattis D., Russ A., Sonawane B. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ. Health Perspect. 2005, 113:1243-1249.
17. Hubner B., Lehnert G., Schaller K.H., Welte D., Angerer J. Chronic occupational exposure to organic solvents. XV. Glycol ether exposure during the manufacture of brakehoses. Int. Arch. Occup. Environ. Health 1992, 64:261-264.
18. Johanson G., Dynésius B. Liquid/air partition coefficients of six commonly used glycol ethers. Br. J. Ind. Med. 1988, 45(8):561-564.
19. Jones K., Dyne D., Cocker J., Wilson H.K. A biological monitoring study of 1-methoxy-2-propanol: analytical method development and a human volunteer study. Sci. Total Environ. 1997, 199:23-30.
20. Kennedy M.J. Hormonal regulation of hepatic drug metabolizing enzyme activity during adolescence. Clin. Pharmacol. Ther. 2008, 84:662-673.
21. Kirman C.R., Sweeney L.M., Corley R.A., Gargas M.L. Using physiologically based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate. Risk Analysis 2005, 25:271-284.
22. Kolloffel W.J., Weekers L.E., Goldhoorn P.B. Pharmacokinetics of propylene glycol after rectal administration. Pharm. World Sci. 1996, 18:109-113.
23. Laparé S., Tardif R., Brodeur J. Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. II. 1-1-1-Trichloroethane and trichloroethylene. Int. Arch. Occup. Environ. Health 1995, 67:375-394.
24. Miller R.R. Metabolism and disposition of glycol ethers. Drug Metab. Rev. 1987, 18:1-22.
25. Miller R.R., Langvardt P.W., Calhoun L.L., Yahrmarkt M.A. Metabolism and disposition of propylene glycol monomethyl ether (PGME) beta isomer in male rats. Toxicol. Appl. Pharmacol. 1986, 83:170-177.
26. Mitchell S.J., Kane A.E., Hilmer S.N. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr. Gerontol. Geriatr. Res. 2011, 624156. Epub 11 May 2011.
27. Pierrehumbert G., Droz P.-O., Tardif R., Charest-Tardif G., Truchon G. Impact of human variability on the biological monitoring of exposure to toluene, phenol, lead, and mercury. II. Compartmental based toxicokinetic modelling. Toxicol. Lett. 2002, 134:165-175.
28. SFSO Les scénarios de l'évolution de la population de la Suisse 2010-2060 2010, Swiss Federal Statistical Office, Available at: http://www.bfs.admin.ch/bfs/portal/fr/index/news/publikationen.Document.132793.pdf.
29. Sobus J.R., Pleil J.D., McClean M.D., Herrick R.F., Rappaport S.M. Biomarker variance component estimation for exposure surrogate selection and toxicokinetic inference. Toxicol. Lett. 2010, 199:247-253.
30. Speth P., Vree T.B., Neilen N.F.M., de Mulder P.H.M., Newell D.R., Gore M.E., de Pauw B.E. Propylene glycol pharmacokinetics and effects after intravenous infusion in humans. Ther. Drug Monit. 1987, 9:255-258.
31. Stott W.T., McKenna M.J. The comparative absorption and excretion of chemical vapors by the upper, lower, and intact respiratory tract of rats. Fund. Appl. Toxicol. 1984, 4:594-602.
32. SUVA, S.N.A.I.F. Valeurs limites d'exposition aux postes de travail 2011 2011, SUVA, Lucerne.
33. Thomas R.S., Bigelow P.L., Keefe T.J., Yang R.S.H. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Am. Ind. Hyg. Assoc. J. 1996, 57(1):23-32.
34. Tomicic C., Berode M., Oppliger A., Castella V., Leyvraz F., Praz-Christinaz S.-M., Danuser B. Sex differences in urinary levels of several biological indicators of exposure: a human volunteer study. Toxicol. Lett. 2011, 202:218-225.
35. Tomicic C., Berode M. Sensitive headspace gas chromatography analysis of free and conjugated 1-methoxy-2-propanol in urine. Anal. Bioanal. Chem. 2010, 396:2709-2714.
36. Tomicic C., Droz P.-O. Age differences in biological monitoring of chemical exposure: a tentative description using a toxicokinetic model. Int. Arch. Occup. Environ. Health 2009, 82:669-676.
37. Tomicic, C., Vernez, D. Sex differences in urinary levels of several biological indicators of exposure: a simulation study using a general compartmental based toxicokinetic model. Int. Arch. Occup. Environ. Health (unpublished data).
38. Toossi M. Employment outlook: 2008-18: labor force projections to 2018: older workers staying more active. Mon. Labor. Rev. 2009, 132:30-51.
39. Truchon G., Tardif R., Droz P.-O., Charest-Tardif G., Pierrehumbert G. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling. J. Occup. Environ. Hyg. 2006, 3:137-143.
40. World Health Organization Biological Monitoring of Chemical Exposure in the Workplace 1996, World Health Organization, Geneva.
41. Yoshimura N., Chancellor M.B. Differential diagnosis and treatment of impaired bladder emptying. Rev. Urol. 2004, 6:S24-S31.
42. Yu D.K., Elmquist W.F., Sawchuk R.J. Pharmacokinetics of propylene glycol in humans during multiple dosing regimens. J. Pharma. Sci. 1985, 74:876-879.
43. Yu D.K., Sawchuk R.J. Pharmacokinetics of propylene glycol in the rabbit. J. Pharmacokinet. Biop. 1987, 15:453-471.
44. Yun K.U., Oh S.J., Oh J.M., Kang K.W., Myung C.-S., Song G.Y., Kim B.-H., Kim S.K. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats. Arch. Toxicol. 2010, 84:939-946.
45. Zeeh J., Platt D. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002, 48:121-127.